Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps

被引:4
|
作者
Ramkumar, Shreya P. [1 ,2 ]
Lal, Devyani [1 ]
Miglani, Amar [1 ]
机构
[1] Mayo Clin Hosp, Dept Otolaryngol Head & Neck Surg, Phoenix, AZ USA
[2] St Louis Univ, Sch Med, St Louis, MO USA
来源
FRONTIERS IN ALLERGY | 2023年 / 4卷
关键词
chronic rhinosinusitis (CRS); shared decision making; biologics; nasal polyps (NP); treatment; ENDOSCOPIC SINUS SURGERY; IN-OFFICE TREATMENT; ADULT CHRONIC RHINOSINUSITIS; HEALTH OUTCOMES; ADHERENCE; IMPLANTS; BARRIERS; EFFICACY; CORTICOSTEROIDS; COMPLICATIONS;
D O I
10.3389/falgy.2023.1137907
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Shared decision-making is an approach where physicians and patients work together to determine a personalized treatment course. Such an approach is integral to patient-centered care in chronic rhinosinusitis with nasal polyps (CRSwNP). CRSwNP is a chronic inflammatory condition of the sinonasal cavity that can severely impact physical health, smell, and quality of life (QOL). Traditional standard-of-care treatment options include topical (i.e. sprays) and oral corticosteroids and endoscopic sinus surgery, but more recently, novel corticosteroid delivery methods (i.e. high volume irrigations, recently-approved exhalation breath-powered delivering devices, and drug-eluting steroid implants) and 3 new FDA approved biologics directed against type II immunomodulators have become available. The availability of these therapeutics offers exciting new opportunities in CRSwNP management but requires personalized and shared-decision making as each modality has variable impacts on CRSwNP and related comorbid conditions. Studies have published treatment algorithms, but the practical use of these lean guidelines is heavily influenced by the lens of the treating physician, the most common being otolaryngologists and allergy immunologists. Clinical equipoise occurs when there is no basis for one intervention to be regarded as "better" than another. While most guidelines, in general, support the use of topical corticosteroids with or without oral corticosteroids followed by ESS for the majority of unoperated CRSwNP patients, there are situations of clinical equipoise that arise particularly in CRSwNP who have failed surgery or those with severe comorbid conditions. In the shared decision-making process, clinicians and patients must consider symptomatology, goals, comfort, compliance, treatment efficacy, and treatment cost when determining the initial choice of therapy and escalation of therapy with the potential use of multiple modalities for recalcitrant CRSwNP. A summary of salient considerations that might constitute shared decision-making is presented in this summary.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] INDIRECT TREATMENT COMPARISON OF BIOLOGICS USED FOR THE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
    Peters, A.
    Han, J.
    Hellings, P.
    Heffler, E.
    Gevaert, P.
    Bachert, C.
    Xu, Y.
    Chuang, C.
    Mannent, L.
    Guyot, P.
    Kamat, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S48 - S49
  • [32] Patient characteristics and treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in Canada
    Szabo, Shelagh
    Gendron, Alain
    Deighton, Alison
    Dragan, Roxana
    Detillieux, Gilles
    Prior, Heather
    Noorduyn, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [33] Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps
    Klimek, L.
    Chaker, A.
    Deitmer, T.
    Plontke, S. K.
    Wollenberg, B.
    Bousquet, J.
    Bachert, C.
    HNO, 2021, 69 (11) : 868 - 877
  • [34] Chronic rhinosinusitis with nasal polyps-extension of dupilumab treatment intervals
    Appel, H. M.
    Lochbaum, R.
    Hoffmann, T. K.
    Hahn, J.
    HNO, 2024, 72 (07) : 499 - 503
  • [35] Comparison of Corticosteroids by 3 Approaches to the Treatment of Chronic Rhinosinusitis With Nasal Polyps
    Zhang, Yunyun
    Lou, Hongfei
    Wang, Yang
    Li, Ying
    Zhang, Luo
    Wang, Chengshuo
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (04) : 482 - 497
  • [36] Shared Decision-Making Is Not Patient Decision-Making
    Birnbrich, Alysa
    McCulloch, Patrick C.
    Kraeutler, Matthew J.
    SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2023, 15 (04): : 615 - 616
  • [37] The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
    Patel, Gayatri B.
    Peters, Anju T.
    ENT-EAR NOSE & THROAT JOURNAL, 2021, 100 (01) : 44 - 47
  • [38] The role of cytokines in chronic rhinosinusitis with nasal polyps
    Otto, Bradley A.
    Wenzel, Sally E.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2008, 16 (03): : 270 - 274
  • [39] Chronic rhinosinusitis with nasal polyps in allergic patients
    Sousa, N.
    Santos, A.
    Loureiro, G.
    Tavares, B.
    Loureiro, C.
    Faria, E.
    Chieira, C.
    ALLERGY, 2008, 63 : 594 - 594
  • [40] Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
    Sheridan M. Hoy
    Drugs, 2020, 80 : 711 - 717